Literature DB >> 11387913

Prevention of influenza and pneumococcal pneumonia in Canadian long-term care facilities: how are we doing?

C G Stevenson1, M A McArthur, M Naus, E Abraham, A J McGeer.   

Abstract

BACKGROUND: Influenza and pneumococcal pneumonia are serious health problems among elderly people and a major cause of death in long-term care facilities. We describe the results of serial surveys of vaccination coverage and influenza outbreak management in Canadian long-term care facilities over the last decade.
METHODS: Cross-sectional surveys consisting of questionnaires mailed to all Canadian residential long-term care facilities for elderly people in 1991 and to a random sample of respondents in 1995 and 1999.
RESULTS: The response rates were 83% (430/515) in 1995 and 75% (380/506) in 1999. In 1999 the mean reported rates of influenza vaccination were 83% among residents and 35% among staff, and the mean rate of pneumococcal vaccination among residents was 71%; all 3 rates were significantly higher than those in 1991. The rates were also higher in facilities with an infection control practitioner than in those without such an individual (88% v. 82% for influenza vaccination among residents [p < 0.001], 42% v. 35% for influenza vaccination among staff [p = 0.008] and 75% v. 63% for pneumococcal vaccination among residents [p < 0.001]). Obtaining consent for vaccination on admission to the facility was associated with higher influenza and pneumococcal vaccination rates among residents (p = 0.04 and p < 0.001 respectively). Facilities with higher influenza vaccination rates among residents and staff reported lower rates of influenza outbreaks (p = 0.08 and 0.03 respectively). Despite recommendations from the National Advisory Committee on Immunization, only 50% of the facilities had policies for amantadine prophylaxis during influenza A outbreaks. Amantadine was judged effective in controlling 76% of the influenza A outbreaks and was discontinued because of side effects in 3% of the residents.
INTERPRETATION: Influenza and pneumococcal vaccination rates among residents and staff in Canadian long-term care facilities have increased over the last decade but remain suboptimal. Vaccination of residents and staff against influenza is associated with a reduced risk of influenza outbreaks. Amantadine is effective in controlling influenza outbreaks in long-term care facilities.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11387913      PMCID: PMC81067     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  41 in total

1.  Pneumococcal vaccine.

Authors: 
Journal:  Med Lett Drugs Ther       Date:  1999-09-10       Impact factor: 1.909

2.  Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people.

Authors:  J E Sisk; A J Moskowitz; W Whang; J D Lin; D S Fedson; A M McBean; J F Plouffe; M S Cetron; J C Butler
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

3.  Immunizations in long-term care facilities: policies and practice.

Authors:  K L Nichol; M B Grimm; D C Peterson
Journal:  J Am Geriatr Soc       Date:  1996-04       Impact factor: 5.562

4.  Amantadine use in influenza outbreaks in long-term care facilities.

Authors:  S E Tamblyn
Journal:  CMAJ       Date:  1997-12-01       Impact factor: 8.262

5.  Pneumococcal vaccination in the United States and 20 other developed countries, 1981-1996.

Authors:  D S Fedson
Journal:  Clin Infect Dis       Date:  1998-05       Impact factor: 9.079

Review 6.  Control of influenza outbreaks in the nursing home: guidelines for diagnosis and management.

Authors:  I H Gomolin; H B Leib; N H Arden; F T Sherman
Journal:  J Am Geriatr Soc       Date:  1995-01       Impact factor: 5.562

7.  [Clinical trial of an antipneumococcal vaccine in elderly subjects living in institutions].

Authors:  J Gaillat; D Zmirou; M R Mallaret; D Rouhan; J P Bru; J P Stahl; P Delormas; M Micoud
Journal:  Rev Epidemiol Sante Publique       Date:  1985       Impact factor: 1.019

8.  Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial.

Authors:  W F Carman; A G Elder; L A Wallace; K McAulay; A Walker; G D Murray; D J Stott
Journal:  Lancet       Date:  2000-01-08       Impact factor: 79.321

9.  Effectiveness of influenza vaccine in health care professionals: a randomized trial.

Authors:  J A Wilde; J A McMillan; J Serwint; J Butta; M A O'Riordan; M C Steinhoff
Journal:  JAMA       Date:  1999-03-10       Impact factor: 56.272

10.  Incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or older.

Authors:  P O Honkanen; T Keistinen; L Miettinen; E Herva; U Sankilampi; E Läärä; M Leinonen; S L Kivelä; P H Mäkelä
Journal:  Vaccine       Date:  1999-06-04       Impact factor: 3.641

View more
  21 in total

1.  Semmelweis revisited: the ethics of infection prevention among health care workers.

Authors:  E Rea; R Upshur
Journal:  CMAJ       Date:  2001-05-15       Impact factor: 8.262

2.  A collaborative system-wide response to influenza outbreak management in Saskatoon Health Region.

Authors:  Cordell Neudorf; Aderonke Obayan; Cathy Anderson; Janice Chomyn
Journal:  Can J Public Health       Date:  2003 Sep-Oct

Review 3.  Seasonal influenza vaccination campaigns for health care personnel: systematic review.

Authors:  Po-Po Lam; Larry W Chambers; Donna M Pierrynowski MacDougall; Anne E McCarthy
Journal:  CMAJ       Date:  2010-07-19       Impact factor: 8.262

4.  The effectiveness of vaccine day and educational interventions on influenza vaccine coverage among health care workers at long-term care facilities.

Authors:  Akiko C Kimura; Christine N Nguyen; Jeffrey I Higa; Eric L Hurwitz; Duc J Vugia
Journal:  Am J Public Health       Date:  2007-02-28       Impact factor: 9.308

5.  AMMI Canada position paper: 2012 Mandatory influenza immunization of health care workers.

Authors:  Elizabeth Bryce; Joanne Embree; Gerald Evans; Lynn Johnston; Kevin Katz; Allison McGeer; Dorothy Moore; Virginia Roth; Andrew Simor; Kathryn Suh; Mary Vearncombe
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

6.  Technical guidelines for the application of seasonal influenza vaccine in China (2014-2015).

Authors:  Luzhao Feng; Peng Yang; Tao Zhang; Juan Yang; Chuanxi Fu; Ying Qin; Yi Zhang; Chunna Ma; Zhaoqiu Liu; Quanyi Wang; Genming Zhao; Hongjie Yu
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

7.  Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa.

Authors:  Timothy M Uyeki; Henry H Bernstein; John S Bradley; Janet A Englund; Thomas M File; Alicia M Fry; Stefan Gravenstein; Frederick G Hayden; Scott A Harper; Jon Mark Hirshon; Michael G Ison; B Lynn Johnston; Shandra L Knight; Allison McGeer; Laura E Riley; Cameron R Wolfe; Paul E Alexander; Andrew T Pavia
Journal:  Clin Infect Dis       Date:  2019-03-05       Impact factor: 9.079

8.  Statement on Seasonal Trivalent Inactivated Influenza Vaccine (TIV) for 2010-2011: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).

Authors: 
Journal:  Can Commun Dis Rep       Date:  2010-08-31

Review 9.  Vaccination of healthcare workers to protect patients at increased risk of acute respiratory disease: summary of a systematic review.

Authors:  Gayle P Dolan; Rebecca C Harris; Mandy Clarkson; Rachel Sokal; Gemma Morgan; Mitsuru Mukaigawara; Hiroshi Horiuchi; Rachel Hale; Laura Stormont; Laura Béchard-Evans; Yi-Sheng Chao; Sergey Eremin; Sara Martins; John Tam; Javier Peñalver; Arina Zanuzadana; Jonathan S Nguyen-Van-Tam
Journal:  Influenza Other Respir Viruses       Date:  2013-09       Impact factor: 4.380

10.  Parental intention to have daughters receive the human papillomavirus vaccine.

Authors:  Gina S Ogilvie; Valencia P Remple; Fawziah Marra; Shelly A McNeil; Monika Naus; Karen L Pielak; Thomas G Ehlen; Simon R Dobson; Deborah M Money; David M Patrick
Journal:  CMAJ       Date:  2007-12-04       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.